Bank Of America Corp Adamis Pharmaceuticals Corp Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.1 - $0.3 $1,409 - $4,228	-14,096 Reduced 35.38%	25,742 $3,000
Q4 2022 Feb 10, 2023	BUY	$0.14 - $0.22 $47 - $75	342 Added 0.87%	39,838 $6,000
Q3 2022 Nov 14, 2022	SELL	$0.24 - $0.54 $3 - $8	-16 Reduced 0.04%	39,496 $8,000
Q2 2022 Aug 12, 2022	SELL	$0.34 - $0.57 $537 - $900	-1,580 Reduced 3.85%	39,512 $19,000
Q1 2022 May 16, 2022	BUY	$0.55 - $0.73 $3,594 - $4,771	6,536 Added 18.91%	41,092 $24,000
Q4 2021 Feb 08, 2022	BUY	$0.57 - $1.23 $12,314 - $26,574	21,605 Added 166.82%	34,556 $21,000
Q3 2021 Nov 15, 2021	BUY	$0.92 - $1.18 $1,730 - $2,219	1,881 Added 16.99%	12,951 $13,000
Q2 2021 Sep 13, 2021	BUY	$0.66 - $1.23 $7,306 - $13,616	11,070 New	11,070 $12,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.